# PARALLAX HEALTH SCIENCES, INC.

PARALLAX HEALTH SCIENCES, INC. is a company headquartered in Beverly Hills, CA, United States.

## Company overview

- **Legal name:** PARALLAX HEALTH SCIENCES, INC.
- **Former names in filing history:** Endeavor Power Corp (2008-10-16 to 2014-01-07); Endeavor Uranium, Inc. (2007-11-13 to 2008-12-31); VB Trade Inc (2007-03-05 to 2007-10-24)
- **Classification:** Company
- **Industry (SIC):** 8000 — Services-Health Services
- **Headquarters:** Beverly Hills, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001388410

## About

PARALLAX HEALTH SCIENCES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388410, and its reported industry is Services-Health Services. In 10-K/A filed on 2020-05-20, it reported annual revenue of USD 128,600; net income of USD -12,866,332; total assets of USD 1,359,896 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $128,600 (USD 128,600)
- **Net income:** -$12.9M (USD -12,866,332)
- **Total assets:** $1.4M (USD 1,359,896)
- **Cash and equivalents:** $6,445 (USD 6,445)
- **Operating cash flow:** -$3 (USD -3)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $11,739 (USD 11,739)
- **Net income:** $16.3M (USD 16,289,320)
- **Total assets:** $1.4M (USD 1,364,357)
- **Cash and equivalents:** $262 (USD 262)
- **Operating cash flow:** -$1.3M (USD -1,291,984)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2017 (period ended 2017-12-31)

- **Revenue:** $3.2M (USD 3,195,144)
- **Total assets:** $3.3M (USD 3,340,475)
- **Cash and equivalents:** $2,604 (USD 2,604)
- **Operating cash flow:** -$1.4M (USD -1,358,435)
- **Later filings:** Revenue, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $22.7M (USD 22,749,087)
- **Total assets:** $2.6M (USD 2,623,991)
- **Cash and equivalents:** $63,363 (USD 63,363)
- **Operating cash flow:** -$424,926 (USD -424,926)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2022-05-12 — period 2022-05-11 — CURRENT REPORT
- Form 8-K — filed 2022-03-28 — period 2022-03-23 — CURRENT REPORT
- Form 8-K — filed 2021-09-29 — period 2021-09-23 — CURRENT REPORT
- Form 8-K — filed 2021-08-31 — period 2021-07-09 — CURRENT REPORT
- Form 8-K — filed 2021-08-23 — period 2021-08-16 — CURRENT REPORT
- Form 8-K — filed 2021-07-13 — period 2021-07-07 — CURRENT REPORT
- Form 8-K — filed 2021-04-08 — period 2021-04-06 — CURRENT REPORT
- Form 10-K/A — filed 2020-05-20 — period 2019-12-31 — ANNUAL REPORT-AMENDMENT-XBRL ONLY
- Form 8-K — filed 2020-05-18 — period 2020-05-17 — CURRENT REPORT-LETTER FROM CEO
- Form 10-K — filed 2020-05-18 — period 2019-12-31 — ANNUAL REPORT 12-31-2019
- Form 8-K — filed 2020-05-15 — period 2020-05-14 — CURRENT REPORT
- Form 8-K — filed 2020-04-15 — period 2020-04-13 — CURRENT REPORT

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/parallax-health-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology